JACC Journals

03/15/2026

In Asia, obesity, T2DM, hypertension and dyslipidemia account for >1/3 of cardiovascular mortality.

This state-of-the-art review examines epidemiology, environmental and health-system determinants, and prevention strategies to reduce cardiometabolic risk across the region.

03/14/2026

Multimodality imaging is essential for effective intervention, especially in patients with high procedural risk. This case underscores the importance of tailored strategies in complex cases involving atypical thrombus presentations.

Learn more in :

AbstractBackgroundA 45-year-old woman with a history of pulmonary embolism, Sjogren syndrome, and hypertension presented with shortness of breath and palpitations.Case SummaryComputed tomography an...

03/13/2026

New HCM research: radionuclide-labeled fibroblast activation protein inhibitor (FAPI) imaging detects cardiac fibroblast activation before CMR-identified myocardial remodeling. Early detection may offer new insights into HCM.

Learn more in : https://bit.ly/4dmdTEV

03/13/2026

Affordability remains a key determinant of cardiovascular care. This Data Report analyzes trends in health care affordability among adults with between 2019 and 2024. https://bit.ly/4lrA52x

03/13/2026

The ACC/AHA and 9 other leading medical associations just issued an updated clinical guideline for the management of —abnormal levels of one or more types of lipids or lipoproteins in the blood, including cholesterol and triglycerides. It is estimated 1 in 4 U.S. adults has high levels of low-density lipoprotein-cholesterol (LDL-C), which increase the risk of heart attack and stroke.

Get the details in : https://bit.ly/4cLB0J0

03/12/2026

Cardiovascular care spending continues to rise across the United States. This Data Report examines how national spending trends relate to mortality outcomes and what this means for value in cardiovascular care. 💰📊🫀 https://bit.ly/4169PkN

03/12/2026

This prospective study analyzed 27 different polygenic cardiovascular risk scores (PGS) in 3,620 women with breast cancer. The model performance for CVD risk prediction was not statistically significant. For some outcomes, PGS performed worse among patients who received cardiotoxic cancer treatments. This work highlights the need for continuing research efforts to develop new PGS models specifically for cancer patients, particularly those who are being treated with cardiotoxic therapies.

Learn more in : https://bit.ly/4rpNd9K

03/11/2026

New case series discusses 2 patients who underwent successful percutaneous debulking of left atrial appendage occlusion device-associated thrombi and vegetation in the setting of refractory infective endocarditis with the AngioVac mechanical aspiration system. https://bit.ly/4b511Sj

03/11/2026

subscribers 🎧📚: We value your opinion and want to hear from you! We've created a quick, 5-minute survey about our JACC This Week podcast and would appreciate your input.

Submit your feedback 👇 https://www.surveymonkey.com/r/H759HB2?iqs=9z2zmuetrqclrorv6cigq9o3oiff71hsvnlorvmfup0

Take this survey powered by surveymonkey.com. Create your own surveys for free.

03/10/2026

Power up your presentation with new presentation-ready slides featuring U.S. cardiovascular disease (CVD) statistics from the inaugural 2026 Report. Access curated visuals on burden, mortality, quality of care and disparities – ready to drop into your slides. Download the deck: https://bit.ly/3N8HCX9

03/10/2026

Data shape the future of cardiovascular medicine. This Editor’s Page introduces the series and explores how national cardiovascular data can guide prevention strategies, policy decisions, and clinical priorities moving forward. 📊🫀 https://bit.ly/4ure6Nw

03/10/2026

In this article, Joachimbauer et al. demonstrate that cardiopathogenic CD4+ T cells induce acute yet reversible inflammation-driven myocardial changes, and that the persistence of these cells is a key factor driving functional cardiac remodeling. https://bit.ly/4sc7dhl